reports
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
BONHR BONHEUR ASA
SOC SUBSEA 7 S.A.
PEN PANORO ENERGY ASA
E36 SEABIRD EXPLORATION LTD.
TGS TGS-NOPEC GEOPHYSICAL COMPANY ASA
AKSOO AKER SOLUTIONS ASA
A2QKGG HEXAGON PURUS
VWS VESTAS WIND SYSTEMS
BORR BORR DRILLING LTD
VAR VAR ENERGI ASA
OTL ODFJELL TECHNOLOGY LTD
TOM TOMRA SYSTEMS ASA
PLSV PARATUS ENERGY SERVICES LTD.
- ABGSC Energy Research
- Åsne Holsen
- Daniel Vårdal Haugland
- John Olaisen
- Stian Wibstad
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Julia Sundvall
- Oscar Lindquist
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Julia Sundvall
- Oscar Lindquist
TGS Awarded OBN 4D Contract in GoA
TGS Awarded OBN 4D Contract in GoA OSLO, Norway (20 October 2025) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of an OBN acquisition contract in Gulf of America. The 4D monitor survey is scheduled to commence in Q4 2025, and the acquisition duration is approximately 4.5 months. The contract was not included in the booked position disclosed in TGS’ Q2 2025 presentation. Kristian Johansen, CEO of TGS, commented, "The Gulf of America is a core market for our OBN business, and we are very pleased to secure this contract for a repeat IOC customer. ...
Genmab Announces New Data Demonstrating Investigational Rinatabart Ses...
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100 mg/m2 demonstrated 50% confirmed objective response rate (ORR), including two complete responses (CR), regardless of FRα expressionA Phase 3 trial in endometrial cancer is underwayU.S. FDA recently granted Breakthrough Therapy Designation to Rina-S for advanced endometria...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
- ABGSC Energy Research
- Åsne Holsen
- Daniel Vårdal Haugland
- John Olaisen
- Stian Wibstad
TGS secures Streamer Acquisition Contract
TGS secures Streamer Acquisition Contract OSLO, Norway (15 October 2025) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of a streamer acquisition contract in Africa. Acquisition is scheduled to commence in Q4 this year and the contract has a duration of approximately 50 days. Kristian Johansen, CEO of TGS, commented, "We are very pleased to secure this work program and look forward to supporting our client’s exploration efforts in the region with our proven technology and expertise. By leveraging the Ramform acquisition platform, coupled with ou...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarte...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025 Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; October 14, 2025 – (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by J&J were USD 3,...
- Felix Fischer
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Tanvi Arora
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
- ABGSC Oil & Oil Services Research
- John Olaisen
TGS Q3 2025 Operational Update
TGS Q3 2025 Operational Update OSLO, Norway (8 October 2025) – TGS ASA (“TGS”), a leading global provider of energy data and intelligence, routinely publishes a quarterly operational update six working days after quarter-end. The table below shows TGS’ normalized Ocean Bottom Node (OBN) crew count¹: Q3 2025Q3 2024Normalized crew count Contract11.83.8Normalized crew count Multi-client11.00.0 1) The table shows the average number of crews in operation when assuming a normalized crew size. The table below shows TGS’ allocation of active seismic streamer 3D vessel capacity2: Q3 2025Q3 20...
- ABGSC Shipping & Transport Research
- Henrik Bartnes
- Petter Nystrøm
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
- ABGSC Shipping & Transport Research
- Henrik Bartnes
- Petter Nystrøm
TGS Webcast Details for Q3 2025 Presentation
TGS Webcast Details for Q3 2025 Presentation Oslo, Norway (6 October 2025) - TGS, a leading global provider of energy data and intelligence will release its Q3 2025 results at approximately 07:00 a.m. CEST on 23 October. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 a.m. CEST on 23 October at House of Oslo, Ruseløkkveien 34 in Oslo, Norway. The presentation is open to the public and will be webcasted live. Access and registration for webcast attendees are available by copying and pasting the link below into your browser, or use the link on the front pa...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Martin Mauseth
- Njål Kleiven
- Stian Wibstad
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Acceleratin...
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model Company Announcement Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of approximately USD 8.0 billionProposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to EBITDA by end of 2029 Genmab to host a conference call today at 1:00 PM CEST / 12:00 PM BST / 7:00 AM EDT COPENHAGEN, Denmark; UTRECHT, The Netherlands; September 29, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.